| 000 | 01155 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514160009.0 | ||
| 264 | 0 | _c20031121 | |
| 008 | 200311s 0 0 eng d | ||
| 022 | _a1389-2010 | ||
| 024 | 7 |
_a10.2174/1389201033489711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRíhová, B | |
| 245 | 0 | 0 |
_aClinical implications of N-(2-hydroxypropyl)methacrylamide copolymers. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _cOct 2003 |
||
| 300 |
_a311-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAcrylamides _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKubácková, K | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 4 _gno. 5 _gp. 311-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389201033489711 _zAvailable from publisher's website |
| 999 |
_c14289097 _d14289097 |
||